Tingbo Liang Selected Research

alpha-Fetoproteins (alpha-Fetoprotein)

7/2023	Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy.
1/2023	Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tingbo Liang Research Topics

Disease

119	Neoplasms (Cancer) 05/2024 - 05/2013
45	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 12/2014
34	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 07/2007
27	Adenocarcinoma 04/2024 - 09/2015
16	Carcinogenesis 05/2024 - 02/2013
16	COVID-19 10/2023 - 01/2020
10	Hypoxia (Hypoxemia) 05/2024 - 05/2013
9	Liver Neoplasms (Liver Cancer) 04/2024 - 08/2019
9	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2016
9	Infections 01/2023 - 01/2016
7	Bites and Stings (Sting) 04/2024 - 01/2022
5	Necrosis 03/2024 - 01/2021
5	End Stage Liver Disease 11/2023 - 09/2020
5	Inflammation (Inflammations) 01/2021 - 03/2016
5	Pancreatic Fistula (Pancreatic Fistulas) 01/2020 - 01/2016
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 03/2009
4	Fibrosis (Cirrhosis) 02/2023 - 11/2016
4	Hemorrhage 01/2022 - 01/2005
4	Pneumonia (Pneumonitis) 01/2022 - 01/2020
4	Liver Diseases (Liver Disease) 01/2020 - 02/2002
3	Disease Progression 10/2023 - 01/2017
3	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2016
3	Reinfection 02/2006 - 02/2002
2	Pathologic Constriction (Stenosis) 04/2024 - 01/2019
2	Fever (Fevers) 11/2023 - 01/2020
2	Cytokine Release Syndrome 09/2023 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2017
2	Cholangiocarcinoma 01/2023 - 01/2021
2	Starvation 12/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 12/2022 - 11/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2013

Drug/Important Bio-Agent (IBA)

19	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
11	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2016
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2002
8	InterferonsIBA 04/2024 - 01/2014
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2014
8	Gemcitabine FDA Link 01/2023 - 09/2015
7	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 04/2002
7	folfirinoxIBA 11/2023 - 04/2016
7	AntigensIBA 09/2023 - 07/2014
7	Phosphotransferases (Kinase)IBA 01/2023 - 01/2018
6	sintilimabIBA 08/2023 - 01/2020
5	EnzymesIBA 01/2023 - 01/2020
4	Messenger RNA (mRNA)IBA 03/2024 - 11/2016
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2020
4	Programmed Cell Death 1 ReceptorIBA 07/2023 - 01/2020
4	Oxygen (Dioxygen)IBA 02/2023 - 12/2020
4	Therapeutic UsesIBA 01/2023 - 09/2015
4	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020
4	LigandsIBA 01/2023 - 11/2021
4	CateninsIBA 01/2023 - 05/2013
4	CytokinesIBA 01/2023 - 02/2019
4	Peptides (Polypeptides)IBA 02/2022 - 01/2019
4	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2016
4	Proto-Oncogene Proteins c-metIBA 12/2020 - 01/2020
4	OSI 027IBA 10/2020 - 09/2015
3	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2024 - 01/2018
3	UbiquitinIBA 05/2024 - 01/2018
3	B7-H1 AntigenIBA 04/2024 - 01/2021
3	LipidsIBA 02/2024 - 01/2023
3	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2021
3	Ubiquitin-Specific ProteasesIBA 01/2024 - 11/2018
3	AntibodiesIBA 11/2023 - 11/2021
3	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2023
3	Cell-Free Nucleic AcidsIBA 09/2023 - 01/2019
3	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 01/2017
3	mRNA VaccinesIBA 01/2023 - 01/2021
3	Lamivudine (Epivir)FDA Link 02/2006 - 02/2002
2	Fructose-BisphosphataseIBA 04/2024 - 03/2024
2	Histone Deacetylase InhibitorsIBA 04/2024 - 07/2013
2	Histones (Histone)IBA 04/2024 - 01/2008
2	lenvatinibIBA 04/2024 - 03/2022
2	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2017
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 03/2024 - 01/2022
2	CalciumIBA 02/2024 - 03/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 11/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2023 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 08/2023 - 02/2006
2	Tumor Biomarkers (Tumor Markers)IBA 07/2023 - 01/2023
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2023 - 01/2023
2	Hyaluronic Acid (Hyaluronan)IBA 06/2023 - 01/2023
2	Capsules (Microcapsules)IBA 02/2023 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 12/2020
2	AlbuminsIBA 01/2023 - 03/2010
2	VaccinesIBA 01/2023 - 01/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2022
2	CalcineurinIBA 01/2022 - 01/2021
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2022
2	LTX-315IBA 01/2022 - 01/2022
2	Neutralizing AntibodiesIBA 11/2021 - 01/2020

Therapy/Procedure

49	Therapeutics 05/2024 - 02/2006
32	Immunotherapy 04/2024 - 01/2014
26	Liver Transplantation 04/2024 - 02/2002
19	Drug Therapy (Chemotherapy) 11/2023 - 12/2014
6	Pancreaticoduodenectomy 01/2020 - 01/2016
4	Transplantation 11/2023 - 01/2018
4	Neoadjuvant Therapy 11/2023 - 07/2017
4	Lung Transplantation 01/2022 - 01/2020
3	Hepatectomy 07/2023 - 01/2021
2	Autologous Transplantation 12/2023 - 11/2023